Anzu Partners Promotes Josh Stiling to Principal

Anzu Partners, an investment firm delivering capital and strategic support to breakthrough technology companies, today announced the promotion of Josh Stiling to Principal on its investment team.

XGS Energy and Baker Hughes Announce Strategic Collaboration to Advance Geothermal Development in New Mexico

XGS Energy (“XGS”), a developer of next-generation geothermal power systems, and Baker Hughes, an energy technology company, today announced a strategic collaboration and initial order for Baker Hughes engineering services to advance XGS’s planned 150-megawatt geothermal project in New Mexico. The project, once developed, will support the delivery of clean, round-the-clock power to the Public Service Company of New Mexico’s (PNM) grid in support of Meta’s data center operations in the state.

OTI Lumionics Establishes New Computational Chemistry Benchmark, Outperforming Traditional Quantum Models

OTI Lumionics, a leader in advanced quantum simulations and solutions for next-generation materials discovery, announces a significant breakthrough in computational chemistry. The company has successfully run its Iterative Qubit Coupled Cluster (iQCC) algorithm using NVIDIA accelerated computing, achieving a new benchmark for what’s possible with material design simulations. This innovation enables the simulation of complex molecular systems with higher efficiency, speed and accuracy than ever before.

Niron Magnetics Advances U.S. Permanent Magnet Manufacturing Plans

Niron Magnetics, the leading manufacturer of rare-earth-free Iron Nitride permanent magnets, today announced that it is initiating a formal site selection process for a new high-volume manufacturing (HVM) plant in the U.S. The new plant is intended to significantly expand national production capacity for the next-generation of permanent magnets that are critical across automotive, consumer electronics, industrial, and defense sectors.

ImmunoScape Announces Memorandum of Understanding for Clinical Trial with Premier U.S. Cancer Center

ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures and EDBI that is developing next-generation TCR-based cancer immunotherapies, today announced the execution of a Memorandum of Understanding (MOU) with a premier NCI-designated Comprehensive Cancer Center in the United States, renowned globally for its pioneering history in cellular immunotherapy. This partnership will fast-track ImmunoScape’s “Seed and Boost” platform into the clinic. Concurrently, the company announced a strategic investment from Leonardo DiCaprio.

Codetta Bio Announces Commercial Availability of Concerto™ System and New Customizable Cytokine and Neuroscience Panels at AGBT 2026

Codetta Bio™, a leader in multi-omic solutions that combine ultrasensitive protein quantification with simultaneous RNA and DNA analysis, today announced major product and commercialization milestones at the AGBT General Meeting. The company has transitioned its Concerto™ system to commercial production and has begun installing systems at customer sites. Codetta Bio also unveiled its near-term product roadmap, including the upcoming launch of new customizable panels for multi-omic studies of immunology and neuroscience.

3ME Technology and South 8 Technologies Sign Letter of Intent to Advance Extreme Cold‑Weather Battery Solutions for Defense

South 8 Technologies, a San Diego-based innovator redefining lithium-ion battery performance with its patented LiGas® cell technology, has signed a Letter of Intent (LOI) with 3ME Technology, an Australian‑owned specialist in ultra‑safe lithium‑ion battery systems for defense, mining and maritime operations, to collaborate on the development of next‑generation lithium‑ion battery solutions designed for extreme cold‑weather and Arctic defense operations.

AM Batteries Names Former Maxwell CEO Dr. Franz Fink Chief Commercial Officer to Lead Dry Battery Electrode (DBE) 2.0 Commercialization

AM Batteries (AMB), a pioneer in low-cost, dry-electrode manufacturing technology, today announced that Dr. Franz Fink has joined the company as Chief Commercial Officer.

In this strategic role, Dr. Fink will lead AMB’s commercial efforts to accelerate the industry’s adoption of AMB’s proprietary Dry Battery Electrode (DBE) technology through the sale of high-performance electrodes and specialized manufacturing equipment.

ExOne Global Holdings Announces Board of Directors

ExOne Global Holdings (“ExOne Global” or the “Company”) today announced its Board of Directors, bringing together industrial technology operators, investors, and additive manufacturing leaders with global experience across commercialization, capital formation, and operational execution. The Board will support ExOne Global’s strategic priorities, including disciplined scaling, international market development, and partnership-led growth.